Literature DB >> 31115861

Stroop-related cerebellar and temporal activation is correlated with negative affect and alcohol use disorder severity.

Claire E Wilcox1, Joshua Clifford2, Josef Ling3, Andrew R Mayer3, Rose Bigelow2, Michael P Bogenschutz4, J Scott Tonigan5.   

Abstract

Impairment in cognitive control in alcohol use disorder (AUD) contributes to difficulty controlling alcohol use and, in many populations, difficulties with emotion regulation. However, the most reliable and robust marker of clinically-relevant deficits in cognitive control in AUD is unclear. Our aims were to measure relationships between BOLD signal during a Stroop task and AUD severity and change in BOLD signal and change in drinking over three weeks. We also aimed to explore the relationships between BOLD signal and subjective negative affect. Thirty-three individuals with AUD underwent a multisensory Stroop task during functional magnetic resonance imaging (fMRI), as well as a battery of neuropsychological tests and self-report assessments of negative affect and AUD severity. Greater activation in temporal gyrus and cerebellum during incongruent trials compared to congruent trials was observed, and percent signal change (incongruent minus congruent) in both clusters was positively correlated with AUD severity and self-reported negative affect. Neuropsychological task performance and self-reported impulsivity were not highly correlated with AUD severity. Hierarchical regression analyses indicated that percent signal change (incongruent minus congruent) in cerebellum was independently associated with negative affect after controlling for recent and chronic drinking. In a subset of individuals (n = 23) reduction in cerebellar percent signal change (incongruent minus congruent) was correlated with increases in percent days abstinent over 3 weeks. BOLD activation during this Stroop task may therefore be an important objective marker of AUD severity and negative affect. The potential importance of the cerebellum in emotion regulation and AUD severity is highlighted.

Entities:  

Keywords:  Alcohol use disorder; Cerebellum; Cognitive control; Negative affect; Stroop

Mesh:

Year:  2020        PMID: 31115861      PMCID: PMC6872926          DOI: 10.1007/s11682-019-00126-3

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  72 in total

1.  Inability to Process Negative Emotions in Cerebellar Damage: a Functional Transcranial Doppler Sonographic Study.

Authors:  Michela Lupo; Elio Troisi; Francesca R Chiricozzi; Silvia Clausi; Marco Molinari; Maria Leggio
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

Review 2.  The cerebellum in drug craving.

Authors:  Josep Moreno-Rius; Marta Miquel
Journal:  Drug Alcohol Depend       Date:  2017-02-20       Impact factor: 4.492

3.  Factor structure of the Barratt impulsiveness scale.

Authors:  J H Patton; M S Stanford; E S Barratt
Journal:  J Clin Psychol       Date:  1995-11

4.  Impulsivity and Alcohol Dependence Treatment Completion: Is There a Neurocognitive Risk Factor at Treatment Entry?

Authors:  Claudia I Rupp; J Katharina Beck; Andreas Heinz; Georg Kemmler; Sarah Manz; Katharina Tempel; W Wolfgang Fleischhacker
Journal:  Alcohol Clin Exp Res       Date:  2015-12-19       Impact factor: 3.455

5.  Cognitive control network function in alcohol use disorder before and during treatment with lorazepam.

Authors:  Claire E Wilcox; Andrew R Mayer; Michael P Bogenschutz; Josef Ling; Charlene Dekonenko; Heather Cumbo
Journal:  Subst Use Misuse       Date:  2014-10-07       Impact factor: 2.164

6.  Emotional task-dependent low-frequency fluctuations and methylphenidate: Wavelet scaling analysis of 1/f-type fluctuations in fMRI of the cerebellar vermis.

Authors:  Carl M Anderson; Steven B Lowen; Perry F Renshaw
Journal:  J Neurosci Methods       Date:  2006-01-19       Impact factor: 2.390

7.  Psychometric properties of a short form of the Affective Lability Scale (ALS-18).

Authors:  Amy E Look; Janine D Flory; Philip D Harvey; Larry J Siever
Journal:  Pers Individ Dif       Date:  2010-08-01

8.  Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence.

Authors:  Thomas P Schmidt; David L Pennington; Stephanie L Cardoos; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  J Clin Exp Neuropsychol       Date:  2016-10-03       Impact factor: 2.475

9.  Neural correlates of the individual emotional Stroop in borderline personality disorder.

Authors:  Katja Wingenfeld; Nina Rullkoetter; Christoph Mensebach; Thomas Beblo; Markus Mertens; Stefan Kreisel; Max Toepper; Martin Driessen; Friedrich G Woermann
Journal:  Psychoneuroendocrinology       Date:  2008-11-29       Impact factor: 4.905

10.  Behavioral control in alcohol use disorders: relationships with severity.

Authors:  Eric D Claus; Sarah W Feldstein Ewing; Francesca M Filbey; Kent E Hutchison
Journal:  J Stud Alcohol Drugs       Date:  2013-01       Impact factor: 2.582

View more
  5 in total

1.  Alcohol- and non-alcohol-related interference: An fMRI study of treatment-seeking adults with alcohol use disorder.

Authors:  Laura Murray; Julia C Welsh; Chase G Johnson; Roselinde H Kaiser; Todd J Farchione; Amy C Janes
Journal:  Drug Alcohol Depend       Date:  2022-04-15       Impact factor: 4.852

Review 2.  Anti-saccade as a Tool to Evaluate Neurocognitive Impairment in Alcohol Use Disorder.

Authors:  Yuqi Si; Lihui Wang; Min Zhao
Journal:  Front Psychiatry       Date:  2022-04-27       Impact factor: 5.435

3.  Neural Substrates Underlying Eyeblink Classical Conditioning in Adults With Alcohol Use Disorders.

Authors:  Dominic T Cheng; Laura C Rice; Mary E McCaul; Jessica J Rilee; Monica L Faulkner; Yi-Shin Sheu; Joanna R Mathena; John E Desmond
Journal:  Alcohol Clin Exp Res       Date:  2020-02-16       Impact factor: 3.928

4.  Brain activation and subjective anxiety during an anticipatory anxiety task is related to clinical outcome during prazosin treatment for alcohol use disorder.

Authors:  Claire E Wilcox; Bryon Adinoff; Joshua Clifford; Josef Ling; Katie Witkiewitz; Andrew R Mayer; Kylar M Boggs; Matthew Eck; Michael Bogenschutz
Journal:  Neuroimage Clin       Date:  2020-01-10       Impact factor: 4.881

Review 5.  Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review.

Authors:  Margaux Poireau; Thomas Milpied; Angéline Maillard; Christine Delmaire; Emmanuelle Volle; Frank Bellivier; Romain Icick; Julien Azuar; Cynthia Marie-Claire; Vanessa Bloch; Florence Vorspan
Journal:  Brain Sci       Date:  2022-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.